Elicit Enters Pharma Early R&D Workflows
elicitorg · x · 2026-07-18
Elicit shared a real-world pharma R&D implementation case: human and veterinary drug company Orion Pharma has been using Elicit continuously over the past year, starting with Reports and Systematic Literature Reviews, and later expanding to the newly launched Research Agent.
Orion's ML/AI Scientist stated that Elicit is used to search, aggregate, extract, and interpret vast amounts of scientific literature. Work that previously required reading paper by paper can now be completed in a fraction of the time. As a result, the team can evaluate more targets with the same headcount and complete each assessment earlier.
The focus of this case isn't a single specific feature, but how Elicit integrates into the pharma early discovery workflow to handle highly repetitive literature curation and analysis.
Related event: Orion Pharma Brings Elicit Into Early Drug Research(3 posts)→
More from Companies & People
- Anthropic's IPO Filing Goes Public, Revealing Strong Revenue and Massive Spending — KateClarkTweets · 2026-10-27
- OpenAI Foundation funds UNC tumor antigen project, hiring senior experimental scientist — iskander · 2026-10-27
- Anthropic IPO timing fuels claims anti-open-weights panic is self-serving — mark_k · 2026-10-27
- Anthropic's S-1 reveals over half of $100K+ customers now use both Claude Platform and first-party apps — TechCrunch AI · 2026-10-27
- PhD applicant emails up 4x YoY due to AI — writing without AI now makes you stand out — AI4Code · 2026-10-27
- ROS names Alejandro Hernández Cordero new project lead, eyes 2027 release — ___Mufasaa · 2026-10-27